3-NITRO-20 DIN 02220792
Health Canada record
| Active ingredient(s) | ROXARSONE 20 % |
|---|---|
| Dosage form | Drug Premix |
| Route | Oral |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Veterinary |
| ATC | |
| Original market date | 02-Jun-1998 |
| Current status date | 28-Oct-2013 |
| Source | Health Canada DPD |
Establishment licence of the holder
Alpharma Canada Corporation — licence 100485, not currently licensed, last inspection rating C (2014-11-04).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ROXARSONE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02139677 | 3-NITRO 20 - FMX | A.L. LABORATORIES, INC. | Drug Premix | ROXARSONE 200 G | Cancelled Post Market |
| 00815896 | 3-NITRO-4-HYDROXYPHENYLARSONIC ACID PWR 20% | DAVIS AND LAWRENCE CO. | Drug Premix | ROXARSONE 200 G | Cancelled Post Market |
| 00497061 | SUPER NITRO TWELVE TAB 17.5MG | DOMINION VETERINARY LABORATORIES LTD. | Tablet | ROXARSONE 17.5 MG | Dormant |